What do insurers need to know about Type 2 diabetes interventions and underwriting individuals in remission?
In part two of this video series, Dr. Daniel Zimmerman, RGA Senior Vice President and Head of Global Medical, continues a deep dive into the reversibility and possible cure of Type 2 diabetes mellitus (DM). Dr. Zimmerman reviews the three known interventions aimed at achieving Type 2 diabetes remission and offers guidance for underwriting individuals who are in remission.
At RGA, we are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to discuss and learn more about the RGA capabilities, resources, and solutions.